BME:ALMPharmaceuticals
Almirall (BME:ALM) Stock Faces Rich P/E As 177% Earnings Growth Fuels Bullish Narratives
Almirall (BME:ALM) has put fresh numbers on the table for Q2 2026, reporting revenue of €313.2 million and net income of €24.3 million, alongside trailing twelve month EPS of €0.28 on revenue of €1.16 billion and net income of €59.1 million. The company has seen revenue move from €262.2 million in Q3 2025 to €288.9 million in Q4 2025, €292.4 million in Q1 2026 and now €313.2 million in Q2 2026, with quarterly net income shifting from €12.5 million to €7.1 million, €15.3 million and €24.3...